Of these, LGALS9‐SLC1A5 has recently been reported to be a stable feature associated with live tumor aggressiveness.[35] Therefore, we evaluated the association between the LGALS9‐SLC1A5 interaction score and patient survival time in the TCGA‐THYM dataset. Here, SLC1A5 is linked to neoplasm.